published in Clinical Endocrinology2007; 67:552-556
Category: Endothelin
Nitric oxide, vascular endothelial growth factor and angiopoietin in papillary thyroid carcinoma
published in Journal of Clinical Endocrinology & Metabolismeletter 21 April 2006 – http://jcem.endojournals.Org
Interrelated overexpression of endothelial and inductible nitric oxyde synthetases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma
published in Clinical Endocrinology2006;64:703-710
Endothelin axis expression in medullary thyroid carcinoma : a potential therapeutic target
published in Clinical EndocrinologyAugust 2004, vol. 61, no. 2, pp. 282-284
Increased expression of endothelin-1 converting enzyme in human thyroid carcinoma
published in Clinical Endocrinology2004, vol. 60, no. 1, pp. 146-147
Expression of Endothelin-1 by Adrenocortical carcinoma: a New Target for Anti-Cancer Therapy?
published in Acta Chirurgica belgica2004;104:581-83.
Increased expression of endothelin-1 and its mithogenic receptor ETA in human papillary thyroid carcinoma
published in Clinical EndocrinologySeptember 2003, vol. 59, no. 3, pp. 354-360
Heart failure induced by pheochromocytoma: Laparoscopic treatment and intraoperative changes of several new cardiovascular hormones
published in Hormone Research1999; 51:50-52
Plasma atrial natriuretic factor and catecholamines before and during excision of pheochromocytoma
published in Acta Chirurgica Belgica1991; 91:112-116.